Sjögren's disease: open trials in Netherlands

6 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT07737743
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Universitair Medisch Centrum Groningen, Groningen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-28
NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Trial Treatment · Phase 3 · Vor Biopharma
Brain Research Center Amsterdam B.V., Amsterdam · Frisius MC, Leeuwarden
Registry updated 2026-10-19
NCT07873931
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Bristol-Myers Squibb
Amsterdam · Leiden
Registry updated 2026-10-14
NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Ziekenhuisgroep Twente Stichting, Almelo · Universitair Medisch Centrum Groningen, Groningen · Frisius MC, Leeuwarden · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Maasstad Ziekenhuis Stichting, Rotterdam
Registry updated 2026-10-13
2024-519884-16-00
Ultimate dePletion of autoReactive b cells using Obinutuzumab from sjÖgren's syndrome affected Tissues study- UPROOT study
Trial Treatment · Phase 2 · Radboud universitair medisch centrum Stichting
Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-09-02
NCT06977724
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Trial Treatment · Phase 1 · AbbVie
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-08-10

All Sjögren's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Sjögren's disease: open trials in Netherlands

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Ultimate dePletion of autoReactive b cells using Obinutuzumab from sjÖgren's syndrome affected Tissues study- UPROOT study

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)